Company profile: The Medicines Company
1.1 - Company Overview
Company description
- Provider of innovative, cost-effective medicines to the worldwide hospital marketplace, focused on advancing treatment of critical care patients. Markets Angiomax(R) (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex(R).
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to The Medicines Company
Matrx Pharmaceuticals
HQ: Poland
Website
- Description: Provider of pharmaceuticals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Matrx Pharmaceuticals company profile →
ZymoGenetics
HQ: United States
Website
- Description: Provider of therapeutic protein discovery, development, and early manufacturing, supported by fully integrated research and development capabilities in scientific computing, molecular and cellular biology, protein chemistry, antibody generation and engineering, and clinical expertise; with an early focus on production systems for recombinant proteins.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ZymoGenetics company profile →
Endo
HQ: Ireland
Website
- Description: Provider of branded and generic pharmaceuticals for patient care, offering affordable, high-quality generics and treatments for unmet pelvic health needs; supplies products tailored to Canadian and emerging markets, and engages in public policy advocacy to enhance patient access, alongside a UK tax strategy focused on compliance and responsible planning.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Endo company profile →
Spotlight Innovation
HQ: United States
Website
- Description: Provider of support for commercializing healthcare technologies developed in America's powerhouse academic laboratories, including acquisition and development of medical sector intellectual property; patented Crotoxin administration for IV treatment of pain and neurologic or neuromuscular disorders; FDA-registered EPISORB using cardiotoxin as a cell-penetrating peptide; and cancer and pain therapeutics via Celtic Biotech Iowa.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spotlight Innovation company profile →
Pfizer
HQ: United States
Website
- Description: Provider of biopharmaceutical medicines and health care services, delivering affordable access to safe, effective treatments, including vaccines for infectious diseases (COVID-19, pneumonia, meningitis), oncology therapies, cardiovascular medicines for hypertension and cholesterol, anti-infectives (antibiotics, antivirals), treatments for inflammation and immunology, and therapies for rare genetic disorders addressing unmet medical needs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pfizer company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for The Medicines Company
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to The Medicines Company
2.2 - Growth funds investing in similar companies to The Medicines Company
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for The Medicines Company
4.2 - Public trading comparable groups for The Medicines Company
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →